Manulife (Manufacturers Life Insurance)
BOLD

Manulife (Manufacturers Life Insurance)’s Audentes Therapeutics, Inc BOLD Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-27,113
Closed -$1.62M – 2958
2019
Q4 		$1.62M Sell
27,113
-459
-2% -$17.2K ﹤0.01% 1474
2019
Q3 		$768K Buy
27,572
+197
+0.7% +$6.72K ﹤0.01% 1776
2019
Q2 		$1.04M Buy
27,375
+2,883
+12% +$111K ﹤0.01% 1637
2019
Q1 		$956K Buy
24,492
+2,596
+12% +$74.4K ﹤0.01% 1728
2018
Q4 		$467K Buy
21,896
+450
+2% +$11.6K ﹤0.01% 1998
2018
Q3 		$849K Sell
21,446
-2,585
-11% -$96.4K ﹤0.01% 1909
2018
Q2 		$919K Buy
24,031
+8,401
+54% +$311K ﹤0.01% 1947
2018
Q1 		$469K Buy
15,630
+2,555
+20% +$86.5K ﹤0.01% 2384
2017
Q4 		$408K Buy
13,075
+402
+3% +$11K ﹤0.01% 2460
2017
Q3 		$355K Sell
12,673
-907
-7% -$19.7K ﹤0.01% 2520
2017
Q2 		$260K Buy
13,580
+12,435
+1,086% +$199K ﹤0.01% 2798
2017
Q1 		$20K Buy
1,145
+1,063
+1,296% +$17.2K ﹤0.01% 3543
2016
Q4 		$2K Buy
+82
New +$1.42K ﹤0.01% 4146

Manulife (Manufacturers Life Insurance)'s BOLD Position: Q1 2020 in Review

Manulife (Manufacturers Life Insurance) sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 27,113 shares — an estimated $1.62M sold.

Manulife (Manufacturers Life Insurance) first reported a position in BOLD in Q4 2016 and held it in 13 quarters. The position peaked at $1.62M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Manulife (Manufacturers Life Insurance) reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 27,113 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $1.62M.
  • Manulife (Manufacturers Life Insurance) first reported a position in Audentes Therapeutics, Inc in Q4 2016 and held it in 13 quarters.
  • Manulife (Manufacturers Life Insurance)'s Audentes Therapeutics, Inc position peaked at $1.62M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2020, filed 15 May 2020.